NeuroGenesis
PrivateLast Round
Grant
Aug 5, 2025
Total Funding Raised
$10M
Company Overview
NeuroGenesis is a clinical-stage cellular therapy company that develops treatments for neurodegenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroGenesis Comparables
Compare NeuroGenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brainstorm Cell Therapeutics Inc. | 88% | |
| Regeneration Biomedical, Inc. | 88% | |
| ImStem Biotechnology | 81% | |
NeuroGenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 5, 2025 | ||||
| Series A | Mar 11, 2022 |
Key People
Founding team and executive leadership
NeuroGenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excell Partners | Series A |
| National MS Society | Grant |
| Morgan Stanley | Series A |
| Rhodium Ventures | Series A |
| New York Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors increased 72% MoM, reaching 2.3K.
- May 1, 2025
Monthly visitors grew 664% MoM, reaching 1.2K.
NeuroGenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroGenesis's valuation, stock price, and market status.